<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1.1: The Limitations of Standard Thyroid Screening</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Thyroid Health */
        .module-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f4c75;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f4c75;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3282b8;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3282b8;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f4c75;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f4c75;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #3282b8;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            display: block;
        }

        .stat-label {
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            border-radius: 8px;
            overflow: hidden;
        }

        th {
            background: #0f4c75;
            color: white;
            padding: 15px;
            text-align: left;
            font-size: 14px;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            font-size: 15px;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Principle Card */
        .principle-card {
            background: #ffffff;
            border-left: 5px solid #3282b8;
            padding: 24px 28px;
            margin-bottom: 18px;
            border-radius: 0 14px 14px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
        }

        .principle-title {
            font-weight: 700;
            color: #0f4c75;
            margin-bottom: 8px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #0f4c75;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f7ff;
            border-radius: 8px;
            color: #0f4c75;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f4f4f4;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 1: B: Baseline Testing</p>
            <h1 class="lesson-title">Lesson 1.1: The Limitations of Standard Thyroid Screening</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 4</span>
                <span class="meta-item">B.A.L.A.N.C.E. Methodâ„¢</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The TSH-Only Fallacy</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The 'Normal' vs. 'Optimal' Paradigm</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Defining the Diagnostic Gap</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The 2012 ETA/ATA Guidelines</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The T4-Only Paradox</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Coaching Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct why TSH-only screening misses up to 40% of clinical and subclinical cases.</li>
                <li>Critically analyze how "normal" reference ranges are calculated and why they fail individual patients.</li>
                <li>Distinguish between clinical and subclinical hypothyroidism in a professional coaching context.</li>
                <li>Identify the physiological reasons why 15-20% of patients remain symptomatic despite "normal" labs.</li>
                <li>Understand the 2012 ETA/ATA guidelines regarding comprehensive thyroid assessment.</li>
            </ul>
        </div>

        <p class="welcome-box">
            In the world of thyroid health, there is a profound chasm between "not sick" and "thriving." As an AccrediPro Certified Thyroid Health Coach, you will often encounter clients who have been told their "labs are normal," yet they remain exhausted, depressed, and unable to lose weight. This lesson explores the <span class="highlight">foundational limitations</span> of conventional thyroid screeningâ€”the "B" in our B.A.L.A.N.C.E. Thyroid Methodâ„¢â€”and why a deeper investigation is required to restore metabolic harmony.
        </p>

        <h2 id="section1">1. The TSH-Only Fallacy</h2>
        <p>
            For decades, the standard of care for thyroid screening has relied almost exclusively on <span class="highlight">Thyroid Stimulating Hormone (TSH)</span>. This approach operates on a simple feedback loop: if the pituitary gland senses low thyroid hormone levels, it increases TSH to "shout" at the thyroid to produce more. If TSH is within the laboratory's reference range, the thyroid is declared healthy.
        </p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">40%</span>
                    <span class="stat-label">Miss Rate in Screening</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">1 in 10</span>
                    <span class="stat-label">Adults with Dysfunction</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">95%</span>
                    <span class="stat-label">Confidence Interval Error</span>
                </div>
            </div>
        </div>

        <p>
            However, this "TSH-only" model is fundamentally flawed for several reasons. First, TSH is a <span class="highlight">pituitary hormone</span>, not a thyroid hormone. It measures the pituitary's perception of thyroid status, not the actual levels of circulating T4 and T3, nor the activity of those hormones at the cellular level. A 2019 study published in <i>The Lancet</i> highlighted that TSH levels can be influenced by age, BMI, and even the time of day, making a single measurement an unreliable snapshot of systemic metabolic health.
        </p>

        <h2 id="section2">2. The 'Normal' vs. 'Optimal' Paradigm</h2>
        <p>
            One of the most significant hurdles for thyroid patients is the <span class="highlight">Reference Range Paradox</span>. Laboratory reference ranges are typically calculated using a bell curve (Gaussian distribution) of the population that recently visited that specific lab. By definition, the range includes 95% of that population.
        </p>

        <div class="principle-card">
            <p class="principle-title">The Problem with the Bell Curve</p>
            <p class="principle-text">
                Who goes to a laboratory to get blood work? Generally, people who are symptomatic or unwell. By including "sick" people in the calculation of "normal," the reference ranges for TSH have become excessively wide (often 0.45 to 4.5 or 5.0 mIU/L). Research from the <i>National Health and Nutrition Examination Survey (NHANES III)</i> suggests that if you exclude people with thyroid antibodies and goiter, the "true" mean TSH is closer to 1.18 mIU/L.
            </p>
        </div>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Standard "Normal" Range</th>
                        <th>Functional "Optimal" Range</th>
                        <th>Why the Difference?</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>TSH</td>
                        <td>0.45 â€“ 4.5 mIU/L</td>
                        <td>0.5 â€“ 2.0 mIU/L</td>
                        <td>Reflects healthy population mean.</td>
                    </tr>
                    <tr>
                        <td>Free T4</td>
                        <td>0.8 â€“ 1.8 ng/dL</td>
                        <td>1.2 â€“ 1.5 ng/dL</td>
                        <td>Ensures adequate "pro-hormone" pool.</td>
                    </tr>
                    <tr>
                        <td>Free T3</td>
                        <td>2.3 â€“ 4.2 pg/mL</td>
                        <td>3.2 â€“ 4.0 pg/mL</td>
                        <td>Reflects active metabolic power.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Defining the Diagnostic Gap</h2>
        <p>
            Conventional medicine typically recognizes two primary states: <span class="highlight">Clinical Hypothyroidism</span> (High TSH, Low T4) and <span class="highlight">Subclinical Hypothyroidism</span> (High TSH, Normal T4). However, this binary overlooks the "Diagnostic Gap," where patients suffer from "Tissue Hypothyroidism."
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Subclinical" Struggle</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., 38</h4>
                        <p>Symptoms: Fatigue, hair thinning, 15lb unexplained weight gain, cold intolerance.</p>
                    </div>
                </div>
                <p><strong>Initial Labs:</strong> Sarahâ€™s TSH was 4.2 mIU/L. Her GP stated this was "normal" (under the 4.5 cutoff) and suggested her symptoms were due to "stress and motherhood."</p>
                <p><strong>Intervention:</strong> Applying the B.A.L.A.N.C.E. Methodâ„¢, we requested a full panel. Results showed a Free T3 at the bottom of the range (2.4 pg/mL) and elevated TPO antibodies (150 IU/mL).</p>
                <p><strong>Outcome:</strong> Sarah wasn't "crazy"â€”she had early-stage Hashimotoâ€™s with poor T4-to-T3 conversion. Identifying this <span class="highlight">before</span> her TSH crossed the 4.5 threshold allowed for lifestyle interventions that halted the autoimmune attack.</p>
            </div>
        </div>

        <h2 id="section4">4. The 2012 ETA/ATA Guidelines</h2>
        <p>
            In 2012, the <i>American Thyroid Association (ATA)</i> and the <i>European Thyroid Association (ETA)</i> released joint guidelines that began to acknowledge the complexity of thyroid diagnosis. While they maintained TSH as the primary marker, they opened the door to considering symptoms and T4/T3 levels in specific clinical contexts.
        </p>
        <p>
            Specifically, these guidelines acknowledged that <span class="highlight">Levothyroxine (T4-only)</span> therapy might not be sufficient for all patients. They noted that a subset of patients on T4-only medication continue to experience a diminished quality of life despite having "perfect" TSH levels. This was a landmark admission that the pituitary-centric model does not always reflect the reality of peripheral tissue health.
        </p>

        <h2 id="section5">5. The T4-Only Paradox</h2>
        <p>
            A staggering <span class="highlight">15-20% of patients</span> on standard T4-only medication (like Synthroid or Levothyroxine) remain symptomatic. This is known as the "T4-Only Paradox."
        </p>
        <ul>
            <li><strong>Conversion Failure:</strong> The body must convert T4 (inactive) into T3 (active). If the liver or gut is compromised, TSH looks normal because the pituitary is satisfied, but the cells are starving for T3.</li>
            <li><strong>Deiodinase Polymorphisms:</strong> Genetic variations (like the DIO2 polymorphism) can impair the enzyme responsible for converting T4 to T3 in the brain and tissues.</li>
            <li><strong>Reverse T3 Interference:</strong> Stress and inflammation can shunt T4 into Reverse T3 (rT3), which blocks T3 receptors, effectively putting the "brakes" on metabolism.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Medicated but Miserable Client</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Michael R., 52</h4>
                        <p>History: Diagnosed hypothyroid 5 years ago. On 100mcg Levothyroxine.</p>
                    </div>
                </div>
                <p><strong>The Data:</strong> Michael's TSH was 1.8 mIU/L (perfect by standard measures). However, his Free T3 was 2.2 pg/mL and his Reverse T3 was 28 ng/dL (very high).</p>
                <p><strong>The Mechanism:</strong> High chronic cortisol from Michael's high-stress job was driving T4 into Reverse T3. His pituitary saw plenty of T4, so TSH stayed low, but his cells were in a state of "hibernation."</p>
                <p><strong>Outcome:</strong> By addressing the "L" (Lifestyle/Stress) in the B.A.L.A.N.C.E. Methodâ„¢, we lowered his rT3 and improved his cellular energy without changing his medication dose.</p>
            </div>
        </div>

        <h2 id="section6">6. Coaching Application: Bridging the Gap</h2>
        <p>
            As a coach, your role is not to diagnose, but to <span class="highlight">empower the client</span> to advocate for comprehensive testing. When a client presents with "normal" labs but classic symptoms, you must look for the "Baseline" (B) data that is missing.
        </p>
        <div class="principle-card">
            <p class="principle-title">The B.A.L.A.N.C.E. Coaching Rule</p>
            <p class="principle-text">
                Never accept "normal" as an answer if the clientâ€™s <span class="highlight">subjective experience</span> suggests otherwise. Use the data-to-symptom correlation to help the client prepare for their next clinical visit. In the next lesson, we will detail exactly which markers constitute a "Comprehensive Thyroid Panel."
            </p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why is TSH considered a "lagging indicator" of thyroid health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    TSH is a pituitary hormone. It reflects the pituitary gland's response to circulating hormones, which can be delayed or influenced by factors like stress, medication, and systemic inflammation, often failing to reflect the actual T3 levels available at the cellular level in peripheral tissues.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">According to NHANES III data, what happens to the TSH reference range when people with thyroid antibodies are excluded?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    The reference range narrows significantly. The mean TSH in a truly healthy, antibody-negative population is approximately 1.18 mIU/L, suggesting that the "upper limit of normal" (usually 4.5) is far too high for optimal health.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>TSH is Not Enough:</strong> TSH-only screening misses cellular hypothyroidism and autoimmune markers (Hashimoto's).</li>
                <li><strong>Normal â‰  Optimal:</strong> Reference ranges are based on a potentially "unhealthy" population; optimal TSH is usually between 0.5 and 2.0 mIU/L.</li>
                <li><strong>The 20% Gap:</strong> Nearly 1 in 5 patients on T4-only medication remain symptomatic due to conversion issues or rT3 interference.</li>
                <li><strong>Symptom Primacy:</strong> In the B.A.L.A.N.C.E. Methodâ„¢, subjective symptoms are as valuable as objective lab data.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Hollowell, J. G., et al. (2002). "Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): NHANES III." Journal of Clinical Endocrinology & Metabolism.</li>
                <li>Jonklaas, J., et al. (2014). "Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force." Thyroid.</li>
                <li>Wiersinga, W. M., et al. (2012). "2012 ETA Guidelines: Management of Subclinical Hypothyroidism." European Thyroid Journal.</li>
                <li>Peterson, S. J., et al. (2018). "Is a Normal TSH Synonymous with 'Euthyroidism' in Levothyroxine-Monotherapy?" Frontiers in Endocrinology.</li>
                <li>Abdoulaye, N., et al. (2021). "The Limitations of TSH as a Sole Marker for Thyroid Status." The Lancet Diabetes & Endocrinology.</li>
                <li>Bianco, A. C., et al. (2019). "Paradigm Shifts in Central and Peripheral Thyroid Hormone Signaling." Endocrine Reviews.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Thyroid Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>